Integral Molecular's Membrane Proteome Array Advances Toward FDA Qualification Integral Molecular is one step closer to obtaining FDA qualification for its Membrane Proteome Array, a vital tool in drug development to assess antibody specificity.

Integral Molecular's Membrane Proteome Array Advances Toward FDA Qualification #USA #Philadelphia #Integral_Molecular #Membrane_Proteome_Array #FDA_Qualification

FDA Accepts Integral Molecular's Membrane Proteome Array Qualification to Boost Drug Development Safeguards Integral Molecular celebrates FDA's acceptance of its Membrane Proteome Array™ as a pivotal Drug Development Tool, enhancing drug safety evaluations.

FDA Accepts Integral Molecular's Membrane Proteome Array Qualification to Boost Drug Development Safeguards #USA #Philadelphia #Drug_Development #Integral_Molecular #Membrane_Proteome_Array